OBSERVATIONAL POST-AUTHORISATION SAFETY STUDY OF VISTABEL® FOR THE TREATMENT OF CROW’S FEET LINES (CFL)

Study identification

• EU PAS number:
  EUPAS15726
• Study ID:
  23614
• Official title and acronym:
  OBSERVATIONAL POST-AUTHORISATION SAFETY STUDY OF VISTABEL® FOR THE TREATMENT OF CROW’S FEET LINES (CFL)
• DARWIN EU® study:
  No
• Study countries:
  Belgium

  France

  Germany

  Sweden

  United Kingdom
• Study description:
  No information provided.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Anita Verga

Study timelines

Date when funding contract was signed

Actual:07/09/2016

Study start date

Planned:26/01/2017

Actual:29/12/2016

Date of final study report

Planned:24/08/2020

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Allergan

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)

Other study registration identification numbers and links

191622-146